课题基金 / 基金详情

Pilot Study of a Developmental Transcriptomic Screen Comparison of Dose-Response in Tissues

Pilot Study of a Developmental Transcriptomic Screen Comparison of Dose-Response in Tissues
组织剂量反应发育转录组筛选比较的初步研究
批准号:
10213573
负责人:
BARNEY SPARROW
金额:
$46.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-26 至 2020-09-25

项目摘要

项目成果

BARNEY SPARROW的其他基金

相似基金

相关文献

中文摘要
翻译
摘要:本项目包括三个子项目。ALL的模型系统是2D或3D的HepaRG细胞。终点是高通量转录组。第一个子项目评估以前在2D HepaRG中评估的选定化学品,在3D HepaRG中评估。第二个项目是使用模型化学品对3D HepaRG系统进行时程评估。此外,还包括样本,以便比较3D HepaRG系统和原代人类肝细胞对模型化学物质的细胞反应。最后一个项目是对几种含水灭火泡沫的评估,以支持正在进行的为缺乏数据的化学品和配方制作基准剂量建模数据的工作。
英文摘要
Abstract: Three sub-projects are included in this project. The model system for all is 2D or 3D HepaRG cells. The endpoint is high throughput transcriptomics. The first sub-project evaluates selected chemicals previously evaluated in 2D HepaRG, in 3D HepaRG. The second project is a time-course evaluation of the 3D HepaRG system using model chemicals. In addition, samples are included to allow comparison of cellular response to model chemcials between the 3D HepaRG system and primary human hepatocytes. The final project is an assessment of several aqueous firefighting foams in support of ongoing work to produce benchmark dose modeling data for data-poor chemicals and formulations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Production of TempOSeq data for the DrugMatrix reference library
  • 批准号:
    10710454
  • 项目类别:
  • 资助金额:
    $110.04万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
Systematic Evaluation of the Application of Zebrafish in Toxicology (SEAZIT) Phase 2
  • 批准号:
    10213572
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
Evaluation of HepaRG cells as a screen for chemical toxicity and assay optimization
  • 批准号:
    10700772
  • 项目类别:
  • 资助金额:
    $3.76万
  • 财政年份:
    2017
  • 负责人:
    BARNEY SPARROW
  • 依托单位:
国内基金
海外基金
企业绩效评价的DEA-Benchmarking方法及动态博弈研究
  • 批准号:
    70571028
  • 项目类别:
    面上项目
  • 资助金额:
    16.5万元
  • 批准年份:
    2005
  • 负责人:
    杨印生
  • 依托单位: